Myths vs facts: FTO and blood sugar

The relationship between FTO gene variants (e.g., rs9939609) and blood sugar is often misunderstood. Myth: The FTO gene directly causes high blood sugar or diabetes. Fact: FTO variants are strongly associated with obesity – they influence appetite, satiety, and energy balance. Obesity, in turn, is the main driver of insulin resistance and elevated blood glucose. Thus, the effect on blood sugar is largely indirect, mediated by BMI. Some studies suggest a small direct effect of FTO on beta-cell function or insulin secretion, but this is clinically modest. Importantly, lifestyle factors (diet, exercise) can substantially mitigate the genetic risk. Carriers of risk variants are not doomed – they often respond even better to weight loss interventions. The evidence is based on large GWAS and meta-analyses (e.g., Frayling et al. 2007, Science). However, a genetic test alone does not predict current blood sugar – fasting glucose and HbA1c are the relevant measures.